Jacques Séguin

Emanate Biomedical, Inc. is an American healthcare technology company that is transforming the standard of care for oral diseases and wounds. Emanate is headquartered in an undisclosed location with a dedicated R&D center in the area and is backed by leading healthcare technology investors. Emanate's patented technology involves personalized single-use preloaded hydrogel-infused dental trays that will improve outcomes with personalized treatment. The company is currently enrolling patients in a clinical study for its first application at the Forsyth Institute in MA. The company was founded by Peter Zegarelli and Jarret Fass, with Jarret Fass serving as the CEO since incorporation.

Emanate Biomedical, Inc. is an American healthcare technology company that is transforming the standard of care for oral diseases and wounds. Emanate is headquartered in an undisclosed location with a dedicated R&D center in the area and is backed by leading healthcare technology investors. Emanate's patented technology involves personalized single-use preloaded hydrogel-infused dental trays that will improve outcomes with personalized treatment. The company is currently enrolling patients in a clinical study for its first application at the Forsyth Institute in MA. The company was founded by Peter Zegarelli and Jarret Fass, with Jarret Fass serving as the CEO since incorporation.